{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04951206",
            "orgStudyIdInfo": {
                "id": "MHRI IRB #STUDY00003851"
            },
            "organization": {
                "fullName": "Medstar Health Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus",
            "officialTitle": "A Randomized Controlled Trial of Vulvar Fractionated CO2-Laser Therapy With and Without Concomitant Topical Clobetasol Propionate 0.05% Ointment for Treatment of Vulvar Lichen Sclerosus",
            "acronym": "VULVIE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "fractionated-laser-with-and-without-clobetasol-for-treatment-of-vulvar-lichen-sclerosus"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-06-22",
            "studyFirstSubmitQcDate": "2021-07-02",
            "studyFirstPostDateStruct": {
                "date": "2021-07-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Medstar Health Research Institute",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Patty Brisben Foundation For Women's Sexual Health",
                    "class": "OTHER"
                },
                {
                    "name": "Society of Gynecologic Surgeons",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized placebo-controlled trial design to determine whether combining FxCO2-laser with the traditional therapy of clobetasol propionate 0.05% ointment (combined treatment) as compared to FxCO2-laser and placebo ointment (FxCO2-laser only) will improve treatment response in women undergoing FxCO2-laser for vulvar lichen sclerosus.\n\nPrimary objective: To evaluate if women with LS who undergo FxCO2 laser therapy and concomitant TCS (clobetasol group) have higher treatment success (defined as a MCID of a \u226516 point improvement in Skindex-29 questionnaire) than those who undergo FxCO2 laser and placebo ointment (placebo group).\n\n* Hypothesis: A higher proportion of women randomized to clobetasol will achieve treatment success as compared to those randomized to placebo.\n* Approach: The proportion of women in each cohort who obtain a \u226516 point improvement in Skindex-29 validated questionnaire score from baseline to final visit will be compared.\n\nSecondary objectives: To compare change in pre- and post-treatment scores on validated questionnaires measuring vulvovaginal symptoms, sexual function, lower urinary tract function, and genital self-image between the clobetasol group compared to the placebo group.\n\n* Hypothesis: Women randomized to clobetasol will demonstrate an equal or greater improvement on validated quality of life questionnaires measuring vulvovaginal symptoms, sexual function, lower urinary tract function, and genital self-image as compared to women randomized to placebo.\n* Approach: Change scores will be calculated to determine change per participant over the treatment period and mean change scores will be compared between cohorts."
        },
        "conditionsModule": {
            "conditions": [
                "Vulvar Lichen Sclerosus"
            ],
            "keywords": [
                "Clobetasol propionate",
                "Fractionated CO2-laser"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 184,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Clobetasol Group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Clobetasol propionate 0.05% ointment is the active treatment arm that will be use in women with lichen sclerosus in the study per standard clinical recommendations. Participants will be instructed to apply 0.25-0.5g of the ointment to the affected tissues nightly for 4 weeks starting after the initial FxCO2 laser treatment, then 2 times a week for the remainder of the study (until final study visit).",
                    "interventionNames": [
                        "Device: Fractionated CO2-laser",
                        "Drug: Clobetasol Propionate 0.05% Ointment"
                    ]
                },
                {
                    "label": "Placebo Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo ointment is the control treatment arm. Participants will be instructed to apply 0.25-0.5g of the ointment to the affected tissues nightly for 4 weeks starting after the initial FxCO2 laser treatment, then 2 times a week for the remainder of the study (until final study visit).",
                    "interventionNames": [
                        "Device: Fractionated CO2-laser"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Fractionated CO2-laser",
                    "description": "All women will be undergoing FxCO2-laser therapy as this treatment is a criterion for enrollment.",
                    "armGroupLabels": [
                        "Clobetasol Group",
                        "Placebo Group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Clobetasol Propionate 0.05% Ointment",
                    "description": "Clobetasol propionate 0.05% ointment obtained from a commercial manufacturer",
                    "armGroupLabels": [
                        "Clobetasol Group"
                    ],
                    "otherNames": [
                        "Clobetasol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Treatment success",
                    "description": "Minimally clinically important difference of a \u226516 point improvement in Skindex-29 validated questionnaire score. Skindex-29 responses are transformed to a linear scale from 0 (no effect) to 100 (effect experienced all the time), and are reported as three scale scores, corresponding to three domains (symptoms, emotions, and functioning). A reduction in Skindex-29 score of 16 points or more has been shown to indicate what is considered a clinically meaningful improvement.",
                    "timeFrame": "About 5 months (baseline to final visit)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Treatment response - vulvovaginal symptoms",
                    "description": "Treatment response - vulvovaginal symptoms will be measured by pre- and post-treatment scores on the vulvovaginal Symptoms Questionnaire, a 21-item survey measuring vulvovaginal symptoms in postmenopausal women.",
                    "timeFrame": "About 5 months (baseline to final visit)"
                },
                {
                    "measure": "Treatment response - sexual function",
                    "description": "Treatment response - sexual function will be measured by pre- and post-treatment scores on the Female Sexual Function Index, a validated questionnaire to assess sexual function.",
                    "timeFrame": "About 5 months (baseline to final visit)"
                },
                {
                    "measure": "Treatment response - genital self image",
                    "description": "Treatment response - genital self image will be measured by pre- and post-treatment scores on the Female Genital Self Image Scale, a validated survey with scores ranging from 7-28 with higher scores indicate a more positive genital self-image.",
                    "timeFrame": "About 5 months (baseline to final visit)"
                },
                {
                    "measure": "Treatment response - lower urinary tract function",
                    "description": "Treatment response - lower urinary tract function will be measured by pre- and post-treatment scores on the LURN SI-10, a 10-item questionnaire with scores ranging from 0 to 38 (higher scores = worse symptoms/bother).",
                    "timeFrame": "About 5 months (baseline to final visit)"
                },
                {
                    "measure": "Participant-perceived improvement",
                    "description": "Patient Global Impression of Improvement (PGI-I): a one single item question that will ask participants to rate their improvement after undergoing treatment on a 7-point Likert scale ranging from \"very much worse\" to \"very much better.\"",
                    "timeFrame": "Final study visit at 4-6 weeks after third Fractionated CO2 laser treatment - one time question"
                },
                {
                    "measure": "Participant-perceived treatment satisfaction",
                    "description": "Level of satisfaction with treatment: a one single item question that will ask participants to rate their level of satisfaction with treatment on a 5-point Likert scale from \"very dissatisfied\" to \"very satisfied\".",
                    "timeFrame": "Final study visit at 4-6 weeks after third Fractionated CO2 laser treatment - one time question"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Women \u2265 18 years old with biopsy confirmed or clinically diagnosed+ LS\n* English-speaking or Spanish-speaking\n* Electing to undergo Fractionated CO2-laser therapy\n* Willing and able to undergo concomitant 0.05% clobetasol propionate treatment\n\nExclusion Criteria:\n\n* Prior surgery with placement vaginal mesh for repair of pelvic organ prolapse (does not include vaginal mesh for anti-incontinence procedure \"sling\" or prior mesh sacrocolpopexy)\n* Prior laser, topical immunomodulators or systemic therapy for LS\n* Active genital infection\\^\n* Suspicious vulvar lesion that has not been evaluated\n* Known vulvar or vaginal malignancy or active treatment for other malignancy\n* Planning pregnancy or pregnant\n* Prior pelvic radiation therapy\n* Topical corticosteroid use on the vulvovaginal tissues in the past 2 weeks\\*\n* Contraindication or allergy to clobetasol propionate 0.05%\n* Currently breast-feeding or lactating\n* History of poor wound healing, keloids or hypertrophic scarring\n* History of a skin condition that could interfere with evaluation of efficacy and safety\n\n  * Eligible for inclusion after washout period of 2 weeks \\^Eligible for inclusion after treatment. For patients with known genital HSV we will instruct them to remain on suppression for the duration of the study.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "This study is investigating treatment of vulvar lichen sclerosus and thus participants will be limited to women with vulvar lichen sclerosus",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alexis Dieter, MD",
                    "role": "CONTACT",
                    "phone": "202-877-6526",
                    "email": "Alexis.a.dieter@medstar.net"
                },
                {
                    "name": "Melissa Gonzales",
                    "role": "CONTACT",
                    "email": "melissa.k.gonzales@medstar.net"
                }
            ],
            "locations": [
                {
                    "facility": "Kaiser Permanente - Southern California Permanente Medical Group",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kimberly Ferrante",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "MedStar Health",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20036",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexis Dieter, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Cheryl Iglesia",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "University of Chicago",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Margaret Mueller",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Kimberly Kenton",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Walter Reed National Military Medical Center",
                    "status": "RECRUITING",
                    "city": "Bethesda",
                    "state": "Maryland",
                    "zip": "20814",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christine Vaccarro",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Meagan Simpson",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.98067,
                        "lon": -77.10026
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emily Von Bargen",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "The University of New Mexico",
                    "status": "RECRUITING",
                    "city": "Albuquerque",
                    "state": "New Mexico",
                    "zip": "87106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kate Meriwether",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08449,
                        "lon": -106.65114
                    }
                },
                {
                    "facility": "Columbia University",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ladin Yurteri-Kaplan",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Ohio State University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisa Hickman",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Silpa Nekkanti",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "The Institute for Female Pelvic Medicine & Reconstructive Surgery",
                    "status": "RECRUITING",
                    "city": "Allentown",
                    "state": "Pennsylvania",
                    "zip": "18103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Akira Gillingham",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.60843,
                        "lon": -75.49018
                    }
                },
                {
                    "facility": "Waukesha Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Waukesha",
                    "state": "Wisconsin",
                    "zip": "53188",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarit Aschkenazi-Steinberg",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01168,
                        "lon": -88.23148
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "22284137",
                    "type": "BACKGROUND",
                    "citation": "Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012 Apr;30(2):231-6, xiii. doi: 10.1016/j.det.2011.11.003. Epub 2011 Dec 20."
                },
                {
                    "pmid": "10782451",
                    "type": "BACKGROUND",
                    "citation": "Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597."
                },
                {
                    "pmid": "21044269",
                    "type": "BACKGROUND",
                    "citation": "Herbenick D, Schick V, Reece M, Sanders S, Dodge B, Fortenberry JD. The Female Genital Self-Image Scale (FGSIS): results from a nationally representative probability sample of women in the United States. J Sex Med. 2011 Jan;8(1):158-66. doi: 10.1111/j.1743-6109.2010.02071.x. Epub 2010 Nov 2."
                },
                {
                    "pmid": "20233278",
                    "type": "BACKGROUND",
                    "citation": "Herbenick D, Reece M. Development and validation of the female genital self-image scale. J Sex Med. 2010 May;7(5):1822-30. doi: 10.1111/j.1743-6109.2010.01728.x. Epub 2010 Mar 3."
                },
                {
                    "pmid": "31135654",
                    "type": "BACKGROUND",
                    "citation": "Hodges KR, Wiener CE, Vyas AS, Turrentine MA. The Female Genital Self-image Scale in Adult Women With Vulvar Lichen Sclerosus. J Low Genit Tract Dis. 2019 Jul;23(3):210-213. doi: 10.1097/LGT.0000000000000481."
                },
                {
                    "pmid": "31364922",
                    "type": "BACKGROUND",
                    "citation": "Cella D, Smith AR, Griffith JW, Kirkali Z, Flynn KE, Bradley CS, Jelovsek JE, Gillespie BW, Helfand BT, Talaty P, Weinfurt KP; LURN Study Group. A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10. J Urol. 2020 Jan;203(1):164-170. doi: 10.1097/JU.0000000000000465. Epub 2019 Jul 31."
                },
                {
                    "pmid": "23481118",
                    "type": "BACKGROUND",
                    "citation": "Erekson EA, Yip SO, Wedderburn TS, Martin DK, Li FY, Choi JN, Kenton KS, Fried TR. The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause. 2013 Sep;20(9):973-9. doi: 10.1097/GME.0b013e318282600b."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007724",
                    "term": "Vulvar Lichen Sclerosus"
                },
                {
                    "id": "D000018459",
                    "term": "Lichen Sclerosus et Atrophicus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017512",
                    "term": "Lichenoid Eruptions"
                },
                {
                    "id": "D000017444",
                    "term": "Skin Diseases, Papulosquamous"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000014845",
                    "term": "Vulvar Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20568",
                    "name": "Lichen Sclerosus et Atrophicus",
                    "asFound": "Lichen Sclerosus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10744",
                    "name": "Vulvar Lichen Sclerosus",
                    "asFound": "Vulvar Lichen Sclerosus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19775",
                    "name": "Lichenoid Eruptions",
                    "relevance": "LOW"
                },
                {
                    "id": "M8219",
                    "name": "Exanthema",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19713",
                    "name": "Skin Diseases, Papulosquamous",
                    "relevance": "LOW"
                },
                {
                    "id": "M17588",
                    "name": "Vulvar Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T3418",
                    "name": "Lichen Sclerosus",
                    "asFound": "Lichen Sclerosus",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002990",
                    "term": "Clobetasol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6223",
                    "name": "Clobetasol",
                    "asFound": "Atropine",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}